Medicinova (MNOV) Non Operating Interest Expenses (2010 - 2018)

Medicinova (MNOV) has reported Non Operating Interest Expenses for 9 consecutive years, with $7815.0 the latest figure, recorded in Q1 2018.

• On a quarterly basis, Non Operating Interest Expenses rose 75.74% year-over-year to $7815.0 in Q1 2018; TTM through Mar 2018 was $28671.0, a 39.98% decrease from a year earlier, with the FY2017 full-year figure at $25303.0, down 45.68% from the prior year.
• Non Operating Interest Expenses was $7815.0 for Q1 2018 at Medicinova, down from $11520.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $28799.0 in Q4 2016 and troughed at $123.0 in Q1 2014.
• A 5-year average of $8755.6 and a median of $6027.0 in 2017 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 97.23% in 2014 and soared 7794.48% in 2015, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $12041.0 in 2014, then increased by 7.2% to $12908.0 in 2015, then surged by 123.11% to $28799.0 in 2016, then slumped by 60.0% to $11520.0 in 2017, then sank by 32.16% to $7815.0 in 2018.
• The last three Non Operating Interest Expenses figures came in at $7815.0 (Q1 2018), $11520.0 (Q4 2017), and $3309.0 (Q3 2017), per Business Quant data.